These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 29103750)

  • 1. Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy.
    Schmitt NC; Kang H; Sharma A
    Oral Oncol; 2017 Nov; 74():40-48. PubMed ID: 29103750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.
    Gilbert MR; Sharma A; Schmitt NC; Johnson JT; Ferris RL; Duvvuri U; Kim S
    JAMA Otolaryngol Head Neck Surg; 2016 May; 142(5):489-95. PubMed ID: 26939990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications.
    Santana T; Pavel A; Martinek P; Steiner P; Grossmann P; Baněčková M; Skálová A
    Hum Pathol; 2019 Nov; 93():37-47. PubMed ID: 31437521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary duct carcinoma of the supraglottis with a distinct presentation: A case report and literature review.
    Hsu CC; Li WY; Chu PY
    Medicine (Baltimore); 2018 Mar; 97(11):e0095. PubMed ID: 29538201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-Line Treatment of Widely Metastatic
    Lin VTG; Nabell LM; Spencer SA; Carroll WR; Harada S; Yang ES
    J Natl Compr Canc Netw; 2018 Oct; 16(10):1166-1170. PubMed ID: 30323086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and oncologic outcomes of 56 salivary duct carcinoma patients in a single institution: high rate of systemic failure warrants targeted therapy.
    Roh JL; Lee JI; Choi SH; Nam SY; Kim SO; Cho KJ; Kim SB; Kim SY
    Oral Oncol; 2014 Nov; 50(11):e64-6. PubMed ID: 25218000
    [No Abstract]   [Full Text] [Related]  

  • 7. Genomic alteration in rare subtype of sarcomatoid salivary duct carcinoma.
    Jeong JS; Cho KJ; Kim D; Lee YS; Song JS
    Pathol Res Pract; 2021 Dec; 228():153678. PubMed ID: 34781210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands.
    Boon E; Bel M; van Boxtel W; van der Graaf WTA; van Es RJJ; Eerenstein SEJ; Baatenburg de Jong RJ; van den Brekel MWM; van der Velden LA; Witjes MJH; Hoeben A; Willems SM; Bloemena E; Smit LA; Oosting SF; ; Jonker MA; Flucke UE; van Herpen CML
    Int J Cancer; 2018 Aug; 143(4):758-766. PubMed ID: 29492965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three new cases of salivary duct carcinoma in the palate: a radiologic investigation and review of the literature.
    Huh KH; Heo MS; Lee SS; Choi SC
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jun; 95(6):752-60. PubMed ID: 12789160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early T Stage Salivary Duct Carcinoma: Outcomes and Implications for Patient Counseling.
    Schmitt NC; Sharma A; Gilbert MR; Kim S
    Otolaryngol Head Neck Surg; 2015 Nov; 153(5):795-8. PubMed ID: 26307577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological features and treatment outcomes of the rare, salivary duct carcinoma of parotid gland.
    Al-Qahtani KH; Tunio MA; Bayoumi Y; Gurusamy VM; Bahamdain FA; Fatani H
    J Otolaryngol Head Neck Surg; 2016 May; 45(1):32. PubMed ID: 27184361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of HER2 in Prognosis of Salivary Duct Carcinoma: A Systematic Review and Meta-Analysis.
    Williams CYK; Townson AT; Terry N; Schmitt NC; Sharma A
    Laryngoscope; 2023 Mar; 133(3):476-484. PubMed ID: 35567387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications.
    Mitani Y; Rao PH; Maity SN; Lee YC; Ferrarotto R; Post JC; Licitra L; Lippman SM; Kies MS; Weber RS; Caulin C; Lin SH; El-Naggar AK
    Clin Cancer Res; 2014 Dec; 20(24):6570-81. PubMed ID: 25316813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular landscape and microenvironment of salivary duct carcinoma reveal new therapeutic opportunities.
    Alame M; Cornillot E; Cacheux V; Tosato G; Four M; De Oliveira L; Gofflot S; Delvenne P; Turtoi E; Cabello-Aguilar S; Nishiyama M; Turtoi A; Costes-Martineau V; Colinge J
    Theranostics; 2020; 10(10):4383-4394. PubMed ID: 32292502
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic Implication of Histopathologic Indicators in Salivary Duct Carcinoma: Proposal of a Novel Histologic Risk Stratification Model.
    Nakaguro M; Sato Y; Tada Y; Kawakita D; Hirai H; Urano M; Shimura T; Tsukahara K; Kano S; Ozawa H; Okami K; Sato Y; Fushimi C; Shimizu A; Takase S; Okada T; Sato H; Imanishi Y; Otsuka K; Watanabe Y; Sakai A; Ebisumoto K; Togashi T; Ueki Y; Ota H; Saigusa N; Takahashi H; Ando M; Hanazawa T; Nagao T
    Am J Surg Pathol; 2020 Apr; 44(4):526-535. PubMed ID: 31764219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma.
    Ku BM; Jung HA; Sun JM; Ko YH; Jeong HS; Son YI; Baek CH; Park K; Ahn MJ
    J Transl Med; 2014 Oct; 12():299. PubMed ID: 25343854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful multimodal treatment of intraoral salivary duct carcinoma in a patient with multiple lymph node metastases: a case report.
    Imaue S; Tomihara K; Hamashima T; Tomizawa G; Nomura K; Sasahara M; Noguchi M
    World J Surg Oncol; 2017 Jan; 15(1):18. PubMed ID: 28073374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary duct carcinoma.
    D'heygere E; Meulemans J; Vander Poorten V
    Curr Opin Otolaryngol Head Neck Surg; 2018 Apr; 26(2):142-151. PubMed ID: 29373327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Salivary duct carcinoma--a clinicopathological analysis of five cases].
    Bień S; Sygut J; Kopczyński J; Postuła S; Ziółkowska M
    Otolaryngol Pol; 2007; 61(1):33-8. PubMed ID: 17605416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIK3CA mutations and PTEN loss in salivary duct carcinomas.
    Griffith CC; Seethala RR; Luvison A; Miller M; Chiosea SI
    Am J Surg Pathol; 2013 Aug; 37(8):1201-7. PubMed ID: 23851329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.